Amgen Inc. buy UBS Group AG
Start price
13.07.26
/
50%
€316.70
Target price
13.07.27
-
Performance (%)
16.02%
Price
18.08.26
€367.45
Summary
This prediction is currently active. The prediction currently has a performance of 16.02%. This prediction currently runs until 13.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.221% | 0.221% |
| iShares Core DAX® | -0,05 % | 5,96 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % |
| iShares S&P 500 | -0,36 % | 2,75 % |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for AMGN provided by MarketBeat